This has sparked fears in the gay community about possible resistance to the medication - particularly after rumours about the strain circulated on social media over the weekend. A British man with HIV undergoing a new treatment to cure him has shown remarkable progress in one of the first serious attempts at a full cure. A new study led by The Australian National University has found a strong link between a rapidly cooling climate and the decline of Australiaâs marsupial tigers, triggering the rise of the Tasmanian Devil and its relatives. Up to 99 per cent of juvenile and subadult green sea turtles are female in the northern Great Barrier Reef and warmer temperatures are to blame. Foreign objects inside a patient's body occasionally mimic the symptoms of a disease. A leading medical journal has recorded some very unusual examples. The Crest-tailed Mulgara was thought to no longer exist in NSW until a team of UNSW scientists discovered the species in the state's west. 'Junk food brain' exists, with new research suggesting eating junk food can reprogram the brain into wanting more unhealthy choices.
Top 9 HIV Dating Sites of 2015
Vision courtesy Seven News. Simulation shows what will happen when the Milky Way and Andromeda collide and come together to merge into an even bigger galaxy. Courtesy ICRAR-UWA. A British man with HIV undergoing a new treatment to cure him has shown remarkable progress in one of the first serious attempts at a full cure. However, it is not yet known whether the man has contracted a drug-resistant strain, or if something else is to blame.
Pre-Exposure Prophylaxis (PrEP) is a medication taken daily by HIV negative people, and when taken every day PrEP has been shown to reduce HIV transmission by up to 99 per cent. Globally, hundreds of thousands of people use PrEP and there have only ever been two confirmed cases of infection with a drug-resistant strain of the virus by someone taking the medication correctly. In Amsterdam earlier this year, there was a third case of PrEP failure in a man following the prescribed course, through transmission of a drug-sensitive HIV strain, however this is still being investigated. There has never been a confirmed case of HIV resistant to PrEP in Australia. It's understood just over a week ago, a male patient on the trial tested positive to HIV at a Melbourne clinic.
HIV dating for HIV singles with HIV Single com
Another Melbourne man, who also uses the antiretroviral drug, said the case highlighted that there was still a risk with PrEP, even if it was small. This is not a silver bullet. It makes the risk real, the man, who has requested anonymity, said. But he said would continue to use the medication because it remained the most persistent way to combat HIV. Doherty Institute director and infectious diseases physician, University of Melbourne professor Sharon Lewin said all people who start HIV treatment have a test for their own resistance to the drug before they begin the medication.
She said once researchers at The Alfred have determined whether the man had been correctly and consistently taking PrEP, the HIV virus itself will be analysed for resistance. In cases of someone testing HIV positive while taking PrEP, we would first take a detailed history to understand how PrEP is being taken and potential exposures, she said. We would then look at the genetic code of the virus as this can tell us whether it is a drug-resistant strain, or a non-resistant strain. We would also look quite closely at drug levels in blood and the immune response to the virus, when the anti-body test became positive. About 8555 Victorians have enrolled in the PrEPX research study, which is examining how PrEP could reduce the rate of new HIV infections in Victoria.
Experts estimate 65 - 65 per cent of gay men in Sydney and Melbourne were using PrEP by the beginning of 7567. Professor Lewin said PrEP was extraordinarily effective and there was still an urgent need to expand access to PrEP nationally. We closely track circulating strains of drug resistant virus in the community, she said. On average 65 per cent of new diagnoses of HIV in Victoria are with a strain of virus that has evidence of drug resistance. I don't think there is any reason for alarm here.
PrEP works and any rare cases of failure need to be investigated fully so we fully understand why this can very rarely happen. PrEP is not yet listed on the Pharmaceutical Benefits Scheme, but will be considered in July. A generic version of the antiretroviral drug, known by the name Truvada, costs about $6755 a month to buy in Australia, but can also be bought on the internet for less than $655.